Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20132677Phase 3Completed
A Phase 3 trial of hyoscine butylbromide in Abdominal discomfort, sponsored by Boehringer Ingelheim. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20132677.